605 followers
RT @FrontNeurol: New Research: Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and Onabotuli…
RT @FrontNeurol: New Research: Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and Onabotuli…
New Research: Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study: Background: German authorities reimburse migraine prevention… https://t.co